It is not only common but also highly reasonable to think that Laboratory Information System (LIS) platforms were designed to handle orders, track samples, and issue reports. Nowadays, however, they’re being asked to do much more: manage growing test volumes, adapt to new diagnostic technologies, and provide actionable insights at speed.
In simple terms – damn, that sounds like a handful.
In the broader reality of actual labwork, labs are no longer passive service providers today – they are now considered core drivers of modern healthcare delivery.
So, where do we go from here, and most importantly, and relevant for you: what are the top priorities and actions you should take this year, for your medical lab?
Interoperability: Beyond Connectivity in Medical Labs
The most pressing demand on LIS platforms is interoperability. Regulatory bodies and healthcare networks are pushing for systems that don’t just “talk” to each other but also share context-rich data. Additionally, standards like HL7 and FHIR enable structured communication, but their adoption is still uneven – even today.
For labs, the challenge isn’t only technical – it’s actually operational: a future-ready LIS will need to exchange data seamlessly across EHRs, national databases, and even patient apps – but without compromising on security or workflow efficiency. In theory, that sounds easy, but in reality, many legacy LIS platforms simply cannot achieve this level of connectivity.
So, what should be your immediate action item? We suggest prioritizing FHIR Adoption – contact your LIS vendor to request a comprehensive interoperability roadmap. Specifically, ask for their timeline on full HL7 FHIR integration to ensure your lab can transition from basic “text sharing” to “context-rich” data exchange.
AI Future-Ready Medical Lab LIS Platforms
It’s not just about the nice, funny images you can create with AI, or the hilarious, ready-made songs that AI music platforms can create within seconds. AI is transforming the diagnostic workflow. In hematology, for example, algorithms can pre-screen slides for abnormalities, reducing manual review time. In microbiology, AI-powered image recognition can flag resistant strains with greater accuracy.
What’s currently missing is a consistent way to embed these capabilities into the LIS itself. Doing that ensures outputs are validated, auditable, and available in real time. However, some platforms already have these capabilities. Making sure your lab is equipped with AI capabilities and integrations could be the difference between catching an early-stage cancer and missing a critical diagnosis.
Your immediate action item should be (in our opinion) to audit your lab’s current “AI Readiness” – review your primary diagnostic workflows (especially in high-volume disciplines like hematology or microbiology) to identify where manual screening creates a bottleneck. Determine if your current LIS can ingest and display AI-flagged anomalies without requiring staff to toggle between separate software windows, as that is a time-waster.
Cloud-First Infrastructure
Cloud adoption is – basically – resilience, in the flesh. A cloud-based LIS will maintain business continuity during disruptions (cyberattacks, surges in testing demand, natural disasters) while reducing the heavy upfront costs of on-premise deployments.
Even more importantly, cloud architecture also accelerates innovation cycles, allowing labs to adopt new features without prolonged downtime or costly upgrades.
The action item here would be tricky, as many LIS vendors will try to talk you out of it… However, we highly recommend you establish a “Zero-Downtime” update schedule. Demand a roadmap from your LIS vendor that utilizes continuous deployment. Your operational goal should be the elimination of “version jumping” – i.e., move toward a system where new features and security patches are rolled out in the background. They rarely do. Usually, they are disruptive, multi-day system overhauls.
What Future-Ready Medical Labs Should Have
The LIS of the future will act less like a database and more like a health data operating system. However, getting there isn’t as simple as one might hope… Labs will need to evaluate their vendors, their internal processes, and the regulatory landscapes with high scrutiny.
Consider the following key questions:
- How interoperable is the system across departments and external networks?
- Does the LIS provide validated pathways for AI-driven diagnostics?
- Can it scale flexibly without adding infrastructure?
- How does the LIS platform empower patients to access and understand their lab results?
- What compliance frameworks are in place?
So, yes – it’s not about storing data and presenting nice-looking reports. Labs must prioritize intuitive and customizable LIS platforms that allow seamless data sharing and safely support AI-driven diagnostics. You’d be surprised to learn how many platforms claim to do that, when they actually don’t…
The Bottom Line
The future LIS is all about redefining the role of laboratories in care delivery. As testing expands into genomics, molecular diagnostics, and personalized medicine, your LIS platform will need to evolve into a platform that drives clinical confidence at scale.
The labs that embrace this transformation early will be the ones shaping – not just following – the next chapter of healthcare.
➡️ BE A SHAPER
